Canadian Cancer Society’s Big Pharma ties question its impartiality on quitting smoking methods
December 02, 2024 by westernstandard.news
Canadian Cancer Society’s Big Pharma ties question its impartiality on quitting smoking methods
The Canadian Cancer Society (CCS) has been a prominent advocate in the fight against tobacco use, championing policies and programs to help Canadians quit smoking. However, questions have been raised about potential conflicts of interest stemming from the organization’s corporate partnerships, which could influence its stance on smoking cessation methods. Relationships between health organizations like the CCS and pharmaceutical companies have become a central topic in discussions about public health recommendations and potential biases. While the CCS remains dedicated to reducing cancer rates and promoting healthy lifestyles, its collaboration with stakeholders, including pharmaceutical companies that manufacture smoking cessation products, continues to be scrutinized.
11.40% of the adult population are current smokers. There are approximately 3.6 million current smokers in Canada 13.70% of men are current smokers but only 9.20% of women.
SOURCE: GSTHR
